vs
Side-by-side financial comparison of Ranpak Holdings Corp. (PACK) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Ranpak Holdings Corp. is the larger business by last-quarter revenue ($93.7M vs $70.6M, roughly 1.3× Viridian Therapeutics, Inc.\DE). On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 2.3%).
Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry, along with automation solutions. The company is based in Concord, Ohio, and has production facilities and offices in Reno, Nevada; Kansas City, Missouri; the Netherlands; Czech Republic; Shanghai and Singapore. The paper packaging material can be used for multiple applications like wrapping, cushioning, void fill and cold chain p...
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
PACK vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $93.7M | $70.6M |
| Net Profit | — | $-34.6M |
| Gross Margin | 39.0% | — |
| Operating Margin | -1.0% | -56.7% |
| Net Margin | — | -49.0% |
| Revenue YoY | 2.3% | 81958.1% |
| Net Profit YoY | — | 54.9% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $93.7M | — | ||
| Q3 25 | $83.6M | $70.6M | ||
| Q2 25 | $77.8M | — | ||
| Q1 25 | $77.6M | — | ||
| Q4 24 | $91.6M | — | ||
| Q3 24 | $78.6M | — | ||
| Q2 24 | $72.8M | — | ||
| Q1 24 | $72.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | $-10.4M | $-34.6M | ||
| Q2 25 | $-7.5M | — | ||
| Q1 25 | $-10.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-8.1M | — | ||
| Q2 24 | $5.5M | — | ||
| Q1 24 | $-8.1M | — |
| Q4 25 | 39.0% | — | ||
| Q3 25 | 41.1% | — | ||
| Q2 25 | 37.1% | — | ||
| Q1 25 | 39.8% | — | ||
| Q4 24 | 45.2% | — | ||
| Q3 24 | 43.8% | — | ||
| Q2 24 | 43.5% | — | ||
| Q1 24 | 44.6% | — |
| Q4 25 | -1.0% | — | ||
| Q3 25 | -6.8% | -56.7% | ||
| Q2 25 | -12.5% | — | ||
| Q1 25 | -10.3% | — | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | -5.3% | — | ||
| Q2 24 | -7.1% | — | ||
| Q1 24 | -6.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | -12.4% | -49.0% | ||
| Q2 25 | -9.6% | — | ||
| Q1 25 | -14.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -10.3% | — | ||
| Q2 24 | 7.6% | — | ||
| Q1 24 | -11.2% | — |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.12 | — | ||
| Q2 25 | $-0.09 | — | ||
| Q1 25 | $-0.13 | — | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | $-0.10 | — | ||
| Q2 24 | $0.07 | — | ||
| Q1 24 | $-0.10 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.0M | $490.9M |
| Total DebtLower is stronger | $401.9M | — |
| Stockholders' EquityBook value | $534.9M | $503.0M |
| Total Assets | $1.1B | $577.1M |
| Debt / EquityLower = less leverage | 0.75× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.0M | — | ||
| Q3 25 | $49.9M | $490.9M | ||
| Q2 25 | $49.2M | — | ||
| Q1 25 | $65.5M | — | ||
| Q4 24 | $76.1M | — | ||
| Q3 24 | $69.5M | — | ||
| Q2 24 | $65.1M | — | ||
| Q1 24 | $55.1M | — |
| Q4 25 | $401.9M | — | ||
| Q3 25 | $403.1M | — | ||
| Q2 25 | $403.1M | — | ||
| Q1 25 | $405.2M | — | ||
| Q4 24 | $406.4M | — | ||
| Q3 24 | $403.2M | — | ||
| Q2 24 | $396.1M | — | ||
| Q1 24 | $396.7M | — |
| Q4 25 | $534.9M | — | ||
| Q3 25 | $537.8M | $503.0M | ||
| Q2 25 | $539.0M | — | ||
| Q1 25 | $544.1M | — | ||
| Q4 24 | $548.1M | — | ||
| Q3 24 | $564.3M | — | ||
| Q2 24 | $566.2M | — | ||
| Q1 24 | $560.0M | — |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $577.1M | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
| Q4 25 | 0.75× | — | ||
| Q3 25 | 0.75× | — | ||
| Q2 25 | 0.75× | — | ||
| Q1 25 | 0.74× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.71× | — | ||
| Q2 24 | 0.70× | — | ||
| Q1 24 | 0.71× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.5M | $-84.6M |
| Free Cash FlowOCF − Capex | — | $-84.7M |
| FCF MarginFCF / Revenue | — | -120.1% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.5M | — | ||
| Q3 25 | $8.5M | $-84.6M | ||
| Q2 25 | $-3.6M | — | ||
| Q1 25 | $-1.3M | — | ||
| Q4 24 | $6.5M | — | ||
| Q3 24 | $10.1M | — | ||
| Q2 24 | $19.6M | — | ||
| Q1 24 | $5.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-84.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -120.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.56× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PACK
| Other | $47.9M | 51% |
| Europe And Asia Segment | $45.8M | 49% |
VRDN
Segment breakdown not available.
